Gsa Capital Partners LLP Novan, Inc. Transaction History

Gsa Capital Partners LLP

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 09, 2022	SELL	$2.29 - $3.86 $146,136 - $246,325	-63,815 Reduced 50.2%	63,306 $148,000
Q1 2022 May 11, 2022	BUY	$2.95 - $4.41 $375,006 - $560,603	127,121 New	127,121 $501,000
Q4 2021 Feb 14, 2022	SELL	$4.03 - $8.15 $359,520 - $727,069	-89,211 Closed	0 $0
Q3 2021 Nov 12, 2021	BUY	$7.48 - $10.17 $565,832 - $769,319	75,646 Added 557.66%	89,211 $726,000
Q2 2021 Aug 05, 2021	BUY	$7.8 - $17.35 $105,807 - $235,352	13,565 New	13,565 $136,000

Ticker NOVN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 21,281,600
Market Cap $638K
Description
Novan, Inc., a pre-commercial nitric oxide-based pharmaceutical company, focuses on dermatology and anti-infective therapies. Its clinical stage dermatology drug candidates include SB204, a topical monotherapy for the treatment of acne vulgaris; SB206, a topical anti-viral gel for the treatment of viral skin infections; SB208, a topical broad-sp...

Get notified when there are updates to the investment portfolio of Gsa Capital Partners LLP, based on Form 13F filings with the SEC.

Stay updated on Gsa Capital Partners LLP with notifications on news.